Unity Biotechnology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Unity Biotechnology, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $0 as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-03-07
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-07 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-07 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-15 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 | |
| 2020-12-31 | $4.10M 10-K · filed 2022-03-15 | $4.09M 10-K · filed 2021-03-23 |
| 2019-12-31 | $7.30M 10-K · filed 2021-03-23 | $7.27M 10-K · filed 2020-03-11 |
| 2018-12-31 | $21.90M 10-K · filed 2020-03-11 | $21.93M 10-K · filed 2019-03-06 |
| 2017-12-31 | $3.30M 10-K · filed 2019-03-06 |